Impaired cognitive function in Crohn's disease: relationship to disease activity

Clarke, G., Kennedy, P.J., Groeger, J.A. ORCID: 0000-0002-3582-1058, Quigley, E.M.M., Shanahan, F., Cryan, J.F. and Dinan, T.G., 2020. Impaired cognitive function in Crohn's disease: relationship to disease activity. Brain, Behavior, and Immunity - Health, 5: 100093. ISSN 2666-3546

[img]
Preview
Text
1343398_a779_Groeger.pdf - Published version

Download (530kB) | Preview

Abstract

Background & aims: Impaired attention and response inhibition have been reported in patients with Crohn’s disease (CD) in clinical remission. Prospective studies are needed to determine whether this is a stable feature of CD and whether a similar impairment is evident in ulcerative colitis (UC). Thus, our aims were to examine whether patients with CD and UC exhibited a persistent impairment in attentional performance, and if this impairment was related to key biological indices of relevance to cognition.

Methods: A prospective observational study was conducted on fifteen patients with CD and 7 with UC in clinical remission recruited from a specialty clinic and 30 healthy matched control participants. A neuropsychological assessment was carried out at baseline (visit 1) and at a 6 month follow-up (visit 2). Plasma proinflammatory cytokines, the plasma kynurenine:tryptophan (Kyn:Trp) ratio and the salivary cortisol awakening response (CAR) were also determined at each visit.

Results: Across visits, patients with CD exhibited impaired attentional performance (p ¼ 0.023). Plasma IL-6 (P ¼ 0.001) and the Kyn:Trp ratio (P ¼ 0.03) were consistently elevated and the CAR significantly blunted (P < 0.05) in patients with CD. No significant relationships were identified between any biochemical parameter and altered cognitive performance.

Conclusions: Impaired cognitive function is a stable feature of patients with CD. These data suggest that even where remission has been achieved, the functional impact of an organic gastrointestinal disorder on cognition is still evident. However, it is unclear at present if physiological changes due to disease activity play a role in cognitive impairment in CD.

Item Type: Journal article
Publication Title: Brain, Behavior, and Immunity - Health
Creators: Clarke, G., Kennedy, P.J., Groeger, J.A., Quigley, E.M.M., Shanahan, F., Cryan, J.F. and Dinan, T.G.
Publisher: Elsevier
Date: May 2020
Volume: 5
ISSN: 2666-3546
Identifiers:
NumberType
10.1016/j.bbih.2020.100093DOI
S2666354620300582Publisher Item Identifier
1343398Other
Rights: © 2020 The Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Divisions: Schools > School of Social Sciences
Record created by: Linda Sullivan
Date Added: 13 Jul 2020 10:16
Last Modified: 07 Aug 2020 13:04
URI: http://irep.ntu.ac.uk/id/eprint/40212

Actions (login required)

Edit View Edit View

Views

Views per month over past year

Downloads

Downloads per month over past year